1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Pennsylvania >
  6. Aprea Therapeutics Acquires Atrin Pharmaceuticals

M&A Deal Summary

Aprea Therapeutics Acquires Atrin Pharmaceuticals

On May 16, 2022, Aprea Therapeutics acquired life science company Atrin Pharmaceuticals

Acquisition Highlights
  • This is Aprea Therapeutics’ 1st transaction in the Life Science sector.
  • This is Aprea Therapeutics’ 1st transaction in the United States.
  • This is Aprea Therapeutics’ 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2022-05-16
Target Atrin Pharmaceuticals
Sector Life Science
Buyer(s) Aprea Therapeutics
Deal Type Add-on Acquisition
Advisor(s) H. C. Wainwright & Co. (Financial)
DLA Piper (Legal)

Target

Atrin Pharmaceuticals

Doylestown, Pennsylvania, United States
Atrin Pharmaceuticals is a private biopharmaceutical company pioneering the discovery & development of proprietary molecules targeting DNA Damage and Response (DDR) pathways to treat a broad spectrum of cancers associated with synthetic lethality and deregulated DNA Damage Response. Atrin Pharmaceuticals is based in Doylestown, Pennsylvania.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Aprea Therapeutics

Doylestown, Pennsylvania, United States
Category Company
Founded 2006
Sector Life Science
Employees8
DESCRIPTION

Aprea Therapeutics is a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53. The Company’s lead product candidate is APR-246, a small molecule in clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Aprea Therapeutics was founded in 2006 and is headquartered in Doylestown, Pennsylvania.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Pennsylvania M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2022 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal